|
Session 158
Poster Abstracts
Renal Disease
Tuesday, 1-4 pm
Room: Hall B |
971
 |
Deterioration of Renal Function Associated with Current Level of Immunodeficiency
Ole Kirk*1, A Mocroft2, A d'Arminio Monforte3, A B Eg Hansen4, J Gatell5, S Caplinskas6, G Fatkenheuer7, P Reiss8, E Vinogradova9, J Lundgren1, and the EuroSIDA Study Group
1Copenhagen HIV Prgm, Univ of Copenhagen, Denmark; 2Royal Free and Univ Coll Med Sch, London, UK; 3Hosp San Paulo, Milan, Italy; 4Rigshospitalet, Copenhagen, Denmark; 5Hosp Clin of Barcelona, Spain; 6Lithuanian AIDS Ctr, Vilnius; 7Univ Hosp Cologne, Germany; 8Univ of Amsterdam, The Netherlands; and 9St Petersburg AIDS Ctr, Russia |
972
|
Chronic Kidney Disease Incidence and Progression to ESRD in HIV-infected Individuals: A Tale of 2 Races
Gregory Lucas*, B Lau, M Atta, D Fine, J Keruly, and R Moore
Johns Hopkins Univ, Baltimore, MD, US |
| 973 |
Proteinuria, Glomerular Filtration Rate Reductions, and Associated Factors among HIV-infected and -uninfected Men in the Multicenter AIDS Cohort Study
Frank Palella*1, X Li2, L Kingsley3, S Gupta4, R Detels5, J Margolick2, J Phair1, and L Jacobson2
1Feinberg Sch of Med, Northwestern Univ, Chicago, IL, US; 2Johns Hopkins Univ, Baltimore, MD, US; 3Univ of Pittsburgh, PA, US; 4Indiana Univ Sch of Med, Indianapolis, US; and 5Univ of California, Los Angeles, US |
974
|
The Effects of HIV-1 Viral Suppression and Non-viral Factors on Clinically Significant Proteinuria in the HAART Era
Samir Gupta*1, N Franceschini2, L Szczech3, M Smurzynski4, R Kalayjian5, and AIDS Clinical Trials Group Longitudinal Linked Randomized Trials (ALLRT) Study Team
1Indiana Univ Sch of Med, Indianapolis, US; 2Univ of North Carolina at Chapel Hill, US; 3Duke Univ, Durham, NC, US; 4Harvard Sch of Publ Hlth, Boston, MA, US; and 5MetroHlth Med Ctr, Cleveland, OH, US |
975
|
Effect of Tenofovir on Renal Function in Patients Using HAART
Michael Horberg*1, B Tang2, W Towner2, S Bersoff-Matcha3, D Klein4, M Silverberg1, W Chen2, L Hurley4, J Chang2, and J Blank3
1Kaiser Permanente, Oakland, CA, US; 2Kaiser Permanente Southern California, Pasadena, US; 3Kaiser Permanente Mid-Atlantic, Washington, DC, US; and 4Kaiser Permanente Northern California, Oakland, US |
976
|
HIV Care and the Incidence of Acute Renal Failure
J Roe, L Campbell, F Ibrahim, B Hendry, and Frank Post*
King`s Coll London, UK |
977a
|
Inefficient Renal Transport of NRTI GS-9148 Indicates Its Low Potential for Nephrotoxicity
G Laflamme1, A Ray1, R Fisher2, R Mackman1, and Tomas Cihlar*1
1Gilead Sci, Foster City CA, US and 2Vitron, Tucson, AZ, US |
977b
|
A Comparison between Different GFR-estimations and [125I]-iothalamate, the Gold Standard for GFR-measurement, in HIV-infected Patients on HAART
Saskia Vrouenraets*1,2, E Fernandez Garcia2, F Wit1,2, K Brinkman3, F Hoek1, R Krediet1, P Reiss1,2, and for the PREPARE Study Group
1Academic Med Ctr, Amsterdam, The Netherlands; 2Intl Antiviral Therapy Evaluation Ctr, Amsterdam, The Netherlands; and 3Onze Lieve Vrouwe Gasthuis, Amsterdam, the Netherlands |
|
